Residency · Residency · Neurology
Transient Ischemic Attack: Risk Stratification and Urgent Workup
Overview
A TIA is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia without evidence of acute infarction on imaging. The modern tissue-based definition from the AHA/ASA distinguishes TIA from stroke by the absence of infarction on diffusion-weighted MRI rather than by symptom duration alone. TIA is a neurological emergency: the 90-day stroke risk is 10-15% without treatment, with the highest risk concentrated in the first 48 hours. Urgent evaluation and initiation of secondary prevention can reduce subsequent stroke risk by up to 80%.
Definition: Time-Based vs Tissue-Based
The traditional time-based definition classified a TIA as any focal neurological deficit lasting less than 24 hours and presumed to be vascular in origin. The modern tissue-based definition reframes TIA as transient neurological symptoms due to ischemia without evidence of acute infarction on diffusion-weighted MRI. This distinction matters because 30-50% of patients whose symptoms last less than 24 hours have DWI-positive lesions, meaning they have suffered strokes by the tissue-based definition. This shift underscores the critical importance of obtaining MRI in the evaluation of suspected TIA.
Clinical Presentation
TIA presents with sudden onset of focal neurological symptoms. Common presentations include unilateral weakness or numbness, aphasia, dysarthria, monocular visual loss (amaurosis fugax), hemianopia, and ataxia. Symptoms typically last minutes to 1-2 hours, with most resolving within 60 minutes. Certain symptoms should not be attributed to TIA: isolated dizziness without other posterior circulation signs, isolated confusion, syncope, bilateral visual blurring, and generalized weakness.
Amaurosis Fugax
Amaurosis fugax is transient monocular visual loss, often described as a "shade" or "curtain" descending over the field of vision. Episodes typically last seconds to minutes. The most common cause is retinal ischemia from carotid artery atherosclerosis producing embolism to the ophthalmic or central retinal artery. Other causes include giant cell arteritis and cardiac embolism. Fundoscopic examination should be performed to look for cholesterol (Hollenhorst) plaques.
Risk Stratification
ABCD2 Score
| Component | Criteria | Points |
|---|---|---|
| Age | ≥ 60 years | 1 |
| Blood pressure | ≥ 140/90 at presentation | 1 |
| Clinical features | Unilateral weakness | 2 |
| Speech disturbance without weakness | 1 | |
| Duration | ≥ 60 minutes | 2 |
| 10–59 minutes | 1 | |
| Diabetes | Present | 1 |
| Total | 0–7 |
| ABCD2 Score | 2-Day Stroke Risk | Risk Category |
|---|---|---|
| 0–3 | ~1% | Low |
| 4–5 | 4–8% | Moderate |
| 6–7 | 8–12% | High |
The ABCD2 score assigns points for age 60 or older (1 point), blood pressure of 140/90 or higher at presentation (1 point), clinical features (unilateral weakness scores 2 points, speech disturbance without weakness scores 1 point), duration (60 minutes or longer scores 2 points, 10-59 minutes scores 1 point), and diabetes (1 point). The total score ranges from 0-7, with higher scores correlating with higher 2-day stroke risk. A score of 4 or above indicates moderate to high risk, corresponding to a 4-8% 2-day stroke risk.
Limitations of ABCD2
The ABCD2 score does not account for the etiology of the TIA, particularly large vessel disease or atrial fibrillation, which are the strongest predictors of recurrent events. It provides poor discrimination at the individual patient level and does not reliably identify low-risk patients who can safely defer evaluation. Many experts and current guidelines now recommend urgent workup for all TIA patients regardless of ABCD2 score. The score should not be used to decide whether to admit a patient or discharge them without workup.
Urgent Workup
Imaging
Brain MRI with DWI is the gold standard, identifying acute infarction in 30-50% of clinical TIAs and reclassifying them as strokes. It should be obtained within 24 hours. CTA or MRA of the head and neck evaluates for large vessel stenosis or occlusion of the carotid, vertebral, and intracranial arteries. Non-contrast CT of the head is used when MRI is unavailable; it rules out hemorrhage and large infarction but misses small acute ischemic lesions.
Cardiac Evaluation
An ECG should be obtained immediately to screen for atrial fibrillation. Continuous cardiac monitoring for at least 24-72 hours inpatient is recommended, with extended outpatient monitoring (14-30 day Holter or event monitor) for cryptogenic events. Echocardiography with TTE serves as an initial screen, with TEE pursued if patent foramen ovale, valvular disease, or intracardiac thrombus is suspected. An implantable loop recorder should be considered for recurrent events without identified etiology, as the CRYSTAL-AF study demonstrated a 30% atrial fibrillation detection rate at 3 years.
Laboratory Studies
The standard workup includes CBC, BMP, coagulation studies, fasting glucose, HbA1c, and fasting lipid panel. ESR and CRP should be obtained if giant cell arteritis or vasculitis is suspected. A hypercoagulability workup is indicated in young patients or those with recurrent events without identified risk factors.
Vascular Assessment
Carotid stenosis of 50% or greater in the symptomatic territory is an indication for revascularization. Assessment of intracranial stenosis is also important, as it may alter the antithrombotic strategy based on data from the WASID and SAMMPRIS trials.
Management
Dual Antiplatelet Therapy
For high-risk TIA (ABCD2 score of 4 or above, or DWI-positive), aspirin plus clopidogrel for 21 days is recommended. Loading doses on day 1 are aspirin 325 mg plus clopidogrel 300 mg. This regimen is based on the CHANCE and POINT trials. After 21 days, patients transition to single antiplatelet therapy with clopidogrel 75 mg or aspirin 81 mg.
Anticoagulation
When atrial fibrillation is identified, a DOAC should be initiated after imaging excludes hemorrhage or large infarct. For non-valvular atrial fibrillation, options include apixaban, dabigatran, rivaroxaban, or edoxaban. Timing of initiation depends on the size of any associated infarct; for TIA with no DWI lesion, it is generally safe to start immediately.
Carotid Revascularization
Symptomatic carotid stenosis of 50% or greater by NASCET criteria warrants CEA or CAS. Timing is critical: revascularization within 2 weeks of the index TIA provides maximal benefit. CEA is preferred for most patients, especially those over 70 (based on CREST data). CAS is a reasonable alternative for patients at high surgical risk or with hostile neck anatomy.
Risk Factor Management
Blood pressure should be targeted below 130/80 mmHg, with initiation of treatment after the acute phase. A high-intensity statin is indicated for all atherosclerotic TIA and stroke. Diabetes management should be optimized. Smoking cessation, exercise, dietary counseling, and weight management are all essential components of secondary prevention.
Emergent vs Outpatient Evaluation
Ideally, all TIA patients should be admitted or observed, especially those with crescendo TIAs, large vessel stenosis, atrial fibrillation, high ABCD2 scores, or positive DWI findings. A rapid outpatient TIA clinic can be equivalent to admission provided the workup is completed within 24 hours. The EXPRESS and SOS-TIA studies demonstrated that urgent clinic-based evaluation with immediate treatment reduced the 90-day stroke risk by approximately 80%. The key determinant of outcome is the speed of evaluation, not the location of care.
TIA Mimics
Common mimics include migraine with aura (distinguished by gradual onset and positive symptoms such as scintillations or marching paresthesias), seizure with postictal deficit (Todd paralysis), hypoglycemia, peripheral vestibular disorders, functional neurological disorder, transient global amnesia (isolated amnesia without focal deficits), and amyloid spells (transient focal symptoms in cerebral amyloid angiopathy).
<image>A diagnostic and management flowchart for TIA. Starting with acute focal neurological symptoms that have resolved, the diagram branches to: (1) emergent non-contrast CT (rule out hemorrhage), (2) brain MRI with DWI (within 24 hours: DWI positive reclassifies as stroke, DWI negative confirms TIA), (3) CTA head and neck (evaluate carotid and intracranial vessels), (4) ECG and cardiac monitoring (detect AF), (5) labs. Based on findings, management pathways include: DAPT x21 days for high-risk TIA, anticoagulation for AF, carotid revascularization within 2 weeks for symptomatic stenosis >=50%, and universal risk factor management. The ABCD2 score is shown in a sidebar with its components and the note about its limitations.</image>
<image>A comparative infographic of TIA vs common mimics. A table format shows TIA, migraine with aura, seizure (with Todd paralysis), transient global amnesia, and functional neurological disorder side by side. For each: typical onset pattern (sudden vs gradual), symptom character (negative vs positive), duration, associated features, and key distinguishing investigations. Color-coded risk indicators highlight which presentations require urgent stroke workup.</image>
<image>An illustration of carotid artery stenosis and revascularization options for symptomatic TIA. The diagram shows a carotid bifurcation with atherosclerotic plaque causing high-grade stenosis, with a Hollenhorst plaque visible in the retinal artery (amaurosis fugax mechanism). Adjacent panels compare CEA (surgical plaque removal) and CAS (stent deployment with embolic protection device), with a summary of NASCET stenosis measurement and the 2-week target for revascularization timing. The number needed to treat from NASCET is annotated for different stenosis grades.</image>
Clinical Pearls
TIA is a neurological emergency because the highest risk of completed stroke occurs within the first 48 hours; same-day workup and treatment initiation can reduce that risk by up to 80%. The ABCD2 score should not be used to defer workup; all TIA patients require urgent evaluation regardless of score. MRI with DWI reclassifies 30-50% of clinical TIAs as strokes, with major implications for management and prognosis. Carotid revascularization must be performed within 2 weeks of the TIA to provide maximal benefit, as delays progressively diminish the treatment effect. Clinicians should always consider TIA mimics such as migraine with aura, seizure, and hypoglycemia, but a mimic diagnosis should never be used as justification to skip vascular imaging. Crescendo TIAs (repeated, frequent episodes) are a red flag for imminent stroke and require emergent hospitalization. Atrial fibrillation is detected in approximately 25% of cryptogenic TIA and stroke patients with prolonged monitoring, so evaluation should not stop at a single normal ECG.
References
- Easton JD, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276-2293.
- Rothwell PM, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study). Lancet. 2007;370(9596):1432-1442.
- Johnston SC, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-292.
- Amarenco P, et al. One-year risk of stroke after transient ischemic attack or minor stroke (TIAregistry.org). N Engl J Med. 2016;374(16):1533-1542.
- Gladstone DJ, et al. Atrial fibrillation in patients with cryptogenic stroke (CRYSTAL-AF). N Engl J Med. 2014;370(26):2467-2477.
